Equities research analysts expect Markel Co. (NYSE:MKL) to report earnings of $8.49 per share for the current quarter, according to Zacks. Three analysts have made estimates for Markel’s earnings. The lowest EPS estimate is $7.62 and the highest is $8.96. Markel reported earnings per share of $9.94 in the same quarter last year, which would indicate a negative year over year growth rate of 14.6%. The company is scheduled to report its next quarterly earnings results after the market closes on Tuesday, July 31st.
On average, analysts expect that Markel will report full-year earnings of $38.31 per share for the current fiscal year, with EPS estimates ranging from $37.95 to $38.67. For the next financial year, analysts expect that the firm will post earnings of $38.93 per share, with EPS estimates ranging from $37.00 to $41.00. Zacks Investment Research’s EPS averages are an average based on a survey of research firms that cover Markel.
Markel (NYSE:MKL) last issued its quarterly earnings data on Tuesday, April 24th. The insurance provider reported $11.39 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $8.71 by $2.68. The firm had revenue of $1.70 billion during the quarter, compared to analysts’ expectations of $1.61 billion. Markel had a net margin of 4.19% and a return on equity of 1.47%.
A number of equities research analysts recently issued reports on MKL shares. Zacks Investment Research upgraded shares of Markel from a “hold” rating to a “buy” rating and set a $1,287.00 price objective for the company in a report on Wednesday, April 11th. Boenning Scattergood set a $1,250.00 price objective on shares of Markel and gave the stock a “buy” rating in a report on Friday, April 27th. Argus started coverage on shares of Markel in a report on Wednesday, April 11th. They issued a “hold” rating for the company. Finally, ValuEngine upgraded shares of Markel from a “sell” rating to a “hold” rating in a report on Monday, April 2nd. One equities research analyst has rated the stock with a sell rating, four have given a hold rating and three have given a buy rating to the company’s stock. Markel presently has a consensus rating of “Hold” and an average target price of $1,237.50.
In other Markel news, Vice Chairman Steven A. Markel sold 200 shares of the company’s stock in a transaction dated Thursday, May 10th. The shares were sold at an average price of $1,147.55, for a total transaction of $229,510.00. Following the completion of the sale, the insider now directly owns 105,040 shares in the company, valued at $120,538,652. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, insider Alan I. Kirshner sold 100 shares of the company’s stock in a transaction dated Monday, July 2nd. The shares were sold at an average price of $1,085.92, for a total transaction of $108,592.00. Following the sale, the insider now owns 23,750 shares of the company’s stock, valued at $25,790,600. The disclosure for this sale can be found here. Insiders have sold 1,390 shares of company stock valued at $1,553,672 over the last 90 days. Corporate insiders own 2.53% of the company’s stock.
A number of hedge funds have recently added to or reduced their stakes in the business. Principal Financial Group Inc. boosted its holdings in Markel by 1.0% during the first quarter. Principal Financial Group Inc. now owns 671,504 shares of the insurance provider’s stock valued at $785,828,000 after acquiring an additional 6,453 shares during the period. Baillie Gifford & Co. boosted its holdings in Markel by 1.1% during the second quarter. Baillie Gifford & Co. now owns 550,655 shares of the insurance provider’s stock valued at $597,103,000 after acquiring an additional 6,226 shares during the period. Summit Trail Advisors LLC boosted its holdings in Markel by 115,809.3% during the first quarter. Summit Trail Advisors LLC now owns 224,864 shares of the insurance provider’s stock valued at $225,000 after acquiring an additional 224,670 shares during the period. Bessemer Group Inc. boosted its holdings in Markel by 1.5% during the second quarter. Bessemer Group Inc. now owns 184,954 shares of the insurance provider’s stock valued at $200,555,000 after acquiring an additional 2,707 shares during the period. Finally, Thrivent Financial for Lutherans boosted its holdings in Markel by 92.6% during the first quarter. Thrivent Financial for Lutherans now owns 94,666 shares of the insurance provider’s stock valued at $110,783,000 after acquiring an additional 45,514 shares during the period. Institutional investors own 76.28% of the company’s stock.
NYSE:MKL traded down $8.57 during trading hours on Friday, reaching $1,150.20. The company’s stock had a trading volume of 25,360 shares, compared to its average volume of 31,538. The stock has a market capitalization of $15.94 billion, a PE ratio of 317.73 and a beta of 0.90. Markel has a one year low of $995.30 and a one year high of $1,194.98. The company has a current ratio of 0.59, a quick ratio of 0.59 and a debt-to-equity ratio of 0.33.
Markel Corporation, a diverse financial holding company, markets and underwrites specialty insurance products in the United States, the United Kingdom, Canada, and internationally. It operates through three segments: U.S. Insurance, International Insurance, and Reinsurance. The U.S. Insurance segment offers general and professional liability, property, personal line, program, and workers' compensation insurance products, as well as other insurance product lines, such as ocean marine, surety, CPI, and coverages.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Markel Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Markel and related companies with MarketBeat.com's FREE daily email newsletter.